Trisubstituted Pyrazolopyrimidines as Novel Angiogenesis Inhibitors

Anti-angiogenic effects of purine inhibitors of cyclin dependent kinases

(2011) Johanna Liebl et al.   ANGIOGENESIS

Roscovitine blocks leukocyte extravasation by inhibition of cyclin-dependent kinases 5 and 9

(2011) Nina Berberich et al.   BRITISH JOURNAL OF PHARMACOLOGY

Twice switched at birth: Cell cycle-independent roles of the “neuron-specific” cyclin-dependent kinase 5 (Cdk5) in non-neuronal cells

(2011) Johanna Liebl et al.   CELLULAR SIGNALLING

The selective P-TEFb inhibitor CAN508 targets angiogenesis

(2011) Vladimír Kryštof et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

Pyrazolo[4,3-d]pyrimidine Bioisostere of Roscovitine: Evaluation of a Novel Selective Inhibitor of Cyclin-Dependent Kinases with Antiproliferative Activity

(2011) Radek Jorda et al.   JOURNAL OF MEDICINAL CHEMISTRY

Molecular mechanisms and clinical applications of angiogenesis

(2011) Peter Carmeliet et al.   NATURE

Anti-angiogenic potential of small molecular inhibitors of cyclin dependent kinases in vitro

(2010) Stefan Zahler et al.   ANGIOGENESIS

Cyclin-dependent Kinase 5 Regulates Endothelial Cell Migration and Angiogenesis

(2010) Johanna Liebl et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Seliciclib in malignancies

(2009) Ibrahim T Aldoss et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS